The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19. (tandfonline.com)

Authors: Kazungu Y … Turner JD Journal: Virulence Published: 2026-07-15 DOI: https://doi.org/10.1080/21505594.2026.2690741